Zervimesine, a Small Sigma‑2 Receptor Selective Modulator for Alzheimer's Disease

泽维美辛,一种用于治疗阿尔茨海默病的选择性小分子σ-2受体调节剂

阅读:1

Abstract

Zervimesine is a small molecule, able to cross the blood-brain barrier, readily available by straightforward organic chemistry processes, showing few "off-target" effects, but displays a potent and selective S2R modulator profile. Evidence suggests Zervimesine can protect synapses and neurons by preventing the toxic effects of soluble Aβ oligomers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。